Oxtoby Andrew
SEC insider (Form 3/4/5 filer). CIK 0001765473. Director at Kalaris Therapeutics, Inc. (KLRS). 3 reported Form 4/5 transactions since Sep 2024; latest on Mar 19, 2026. Located in BERKELEY HEIGHTS, NJ.
Companies Oxtoby Andrew has filed insider reports for
- Kalaris Therapeutics, Inc. (KLRS): Director, Officer, See Remarks
Oxtoby Andrew
CIK: 0001765473
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KLRS
Kalaris Therapeutics, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Mar 19, 2026KLRS
Kalaris Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
222K shares- - Apr 10, 2025KLRS
Kalaris Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
287K shares- - Mar 18, 2025KLRS
Kalaris Therapeutics, Inc.
AwardDirectStock Option (right to buy)
476.6K shares-
1-3 of 3 transactions